Literature DB >> 23578903

Incidence of dementia in older adults with intellectual disabilities.

Andre Strydom1, Trevor Chan, Michael King, Angela Hassiotis, Gill Livingston.   

Abstract

Dementia may be more common in older adults with intellectual disability (ID) than in the general population. The increased risk for Alzheimer's disease in people with Down syndrome (DS) is well established, but much less is known about dementia in adults with ID who do not have DS. We estimated incidence rates from a longitudinal study of dementia in older adults with ID without DS and compared them to general population rates. 222 participants with ID without DS aged 60 years and older were followed up an average of 2.9 years later to identify those who had declined in functional or cognitive abilities. Those who screened positive had a comprehensive assessment for dementia, diagnosed using ICD 10 and DSM IV criteria. 134 participants who did not have dementia at initial assessment were alive and interviewed at follow up; 21 (15.7%) were diagnosed with dementia. Overall incidence rate for those aged ≥ 60 was 54.6/1000 person years (95% CI 34.1-82.3). The highest incidence rate (97.8/1000 person years) was in the age group 70-74. Standardised incidence ratio for those aged ≥ 65 was 4.98 (95% CI 1.62-11.67). Incidence of dementia in older people with intellectual disabilities are up to five times higher than older adults in the general population. Screening may be useful in this population given the high incident rates, particularly as more effective treatments become available. Studies to explore the underlying aetiological factors for dementia associated with intellectual disability could help to identify novel protective and risk factors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23578903     DOI: 10.1016/j.ridd.2013.02.021

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  18 in total

1.  [Mental health in persons with intellectual disability].

Authors:  Matthias Schützwohl; Tanja Sappok
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

Review 2.  Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.

Authors:  Nicole Eady; Ken Courtenay; André Strydom
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 3.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

4.  Cognitive training in adults with intellectual disability: pilot study applying a cognitive tele-rehabilitation program.

Authors:  Javier García-Alba; Susana Rubio-Valdehita; M Julia Sánchez; Amelia I M García; Susanna Esteba-Castillo; Marta Gómez-Caminero
Journal:  Int J Dev Disabil       Date:  2020-05-19

Review 5.  The Medical Care of People With Intellectual Disability.

Authors:  Tanja Sappok; Albert Diefenbacher; Martin Winterholler
Journal:  Dtsch Arztebl Int       Date:  2019-11-29       Impact factor: 5.594

6.  Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia.

Authors:  Wayne P Silverman; Warren B Zigman; Sharon J Krinsky-McHale; Robert Ryan; Nicole Schupf
Journal:  J Policy Pract Intellect Disabil       Date:  2013-09-01

Review 7.  Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities.

Authors:  Eli Carmeli; Bita Imam
Journal:  Front Public Health       Date:  2014-04-14

Review 8.  Oxidative stress, thyroid dysfunction & Down syndrome.

Authors:  Carlos Campos; Ángela Casado
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

Review 9.  A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities.

Authors:  Jordan Elliott-King; Sarah Shaw; Stephan Bandelow; Rajal Devshi; Shelina Kassam; Eef Hogervorst
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-30

Review 10.  Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.

Authors:  Natalie Neale; Concepcion Padilla; Luciana Mascarenhas Fonseca; Tony Holland; Shahid Zaman
Journal:  Neuroimage Clin       Date:  2017-11-06       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.